Literature DB >> 20588258

A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors.

Fang Zhang1, Amy R Frost, Mike P Blundell, Olivia Bales, Michael N Antoniou, Adrian J Thrasher.   

Abstract

DNA methylation may restrict the activity of gene transfer vectors due to inadvertent silencing. In P19 embryonic carcinoma cells in vitro, we found that transgene expression regulated by the SFFV LTR and EF1 alpha promoter declined rapidly within 16 days, but for A2UCOE derived from the human HNRPA2B1-CBX3 housekeeping gene locus, remained completely stable. Silencing correlated with extensive epigenetic methylation of CpG sites, whereas the A2UCOE was almost completely resistant. Linking of the A2UCOE upstream of the SFFV LTR protected this element from both DNA methylation and silencing. Analysis of engrafted hematopoietic cells in vivo transduced with the same vectors revealed a similar pattern. The A2UCOE displayed little or no methylation in either primary or secondary graft recipients, and gene expression profiles were highly conserved between the two groups. These studies provide convincing evidence that DNA methylation plays a direct role in regulating self-inactivating (SIN) lentiviral transgene expression, and that the stability of expression from the A2UCOE is, at least in part, due to methylation resistance. The A2UCOE therefore has considerable utility for gene therapy applications where reliable and sustained gene expression is desirable.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20588258      PMCID: PMC2956914          DOI: 10.1038/mt.2010.132

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  45 in total

Review 1.  Gene silencing as a threat to the success of gene therapy.

Authors:  T H Bestor
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Retroviral expression in embryonic stem cells and hematopoietic stem cells.

Authors:  S R Cherry; D Biniszkiewicz; L van Parijs; D Baltimore; R Jaenisch
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  Activation of silenced transgene expression in neural precursor cell lines by inhibitors of histone deacetylation.

Authors:  Nina Rosenqvist; Caroline Hård Af Segerstad; Christofer Samuelsson; Jens Johansen; Cecilia Lundberg
Journal:  J Gene Med       Date:  2002 May-Jun       Impact factor: 4.565

4.  Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny.

Authors:  C A Klug; S Cheshier; I L Weissman
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

5.  Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code.

Authors:  D Pannell; C S Osborne; S Yao; T Sukonnik; P Pasceri; A Karaiskakis; M Okano; E Li; H D Lipshitz; J Ellis
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

6.  Evidence for repeat-induced gene silencing in cultured Mammalian cells: inactivation of tandem repeats of transfected genes.

Authors:  Michael W McBurney; Tina Mai; Xiaofeng Yang; Karen Jardine
Journal:  Exp Cell Res       Date:  2002-03-10       Impact factor: 3.905

7.  High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.

Authors:  Christophe Demaison; Kathryn Parsley; Gaby Brouns; Michaela Scherr; Karin Battmer; Christine Kinnon; Manuel Grez; Adrian J Thrasher
Journal:  Hum Gene Ther       Date:  2002-05-01       Impact factor: 5.695

8.  Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line.

Authors:  M W McBurney; E M Jones-Villeneuve; M K Edwards; P J Anderson
Journal:  Nature       Date:  1982-09-09       Impact factor: 49.962

9.  Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing.

Authors:  Michael Antoniou; Lee Harland; Tracey Mustoe; Steven Williams; Jolyon Holdstock; Ernesto Yague; Tony Mulcahy; Mark Griffiths; Sian Edwards; Panayiotis A Ioannou; Andrew Mountain; Robert Crombie
Journal:  Genomics       Date:  2003-09       Impact factor: 5.736

10.  Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Authors:  Alessandro Aiuti; Shimon Slavin; Memet Aker; Francesca Ficara; Sara Deola; Alessandra Mortellaro; Shoshana Morecki; Grazia Andolfi; Antonella Tabucchi; Filippo Carlucci; Enrico Marinello; Federica Cattaneo; Sergio Vai; Paolo Servida; Roberto Miniero; Maria Grazia Roncarolo; Claudio Bordignon
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  59 in total

1.  Toward position-independent retroviral vector expression in pluripotent stem cells.

Authors:  Axel Schambach; Thomas Moritz
Journal:  Mol Ther       Date:  2013-08       Impact factor: 11.454

2.  Assessment of UCOE on Recombinant EPO Production and Expression Stability in Amplified Chinese Hamster Ovary Cells.

Authors:  Zeynep Betts; Alan J Dickson
Journal:  Mol Biotechnol       Date:  2015-09       Impact factor: 2.695

3.  A Lentiviral Fluorescent Genetic Barcoding System for Flow Cytometry-Based Multiplex Tracking.

Authors:  Tobias Maetzig; Jens Ruschmann; Courteney K Lai; Mor Ngom; Suzan Imren; Patricia Rosten; Gudmundur L Norddahl; Niklas von Krosigk; Lea Sanchez Milde; Christopher May; Anton Selich; Michael Rothe; Ishpreet Dhillon; Axel Schambach; R Keith Humphries
Journal:  Mol Ther       Date:  2017-01-05       Impact factor: 11.454

4.  Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.

Authors:  Fang Han; Yoshitaka Miyagawa; Gianluca Verlengia; Selene Ingusci; Marie Soukupova; Michele Simonato; Joseph C Glorioso; Justus B Cohen
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 5.  Engineering humanized mice for improved hematopoietic reconstitution.

Authors:  Adam C Drake; Qingfeng Chen; Jianzhu Chen
Journal:  Cell Mol Immunol       Date:  2012-03-19       Impact factor: 11.530

6.  Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.

Authors:  Stifani Satkunanathan; Jun Wheeler; Robin Thorpe; Yuan Zhao
Journal:  Hum Gene Ther       Date:  2014-09-11       Impact factor: 5.695

7.  Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells.

Authors:  D Hoffmann; J W Schott; F K Geis; L Lange; F-J Müller; D Lenz; D Zychlinski; D Steinemann; M Morgan; T Moritz; A Schambach
Journal:  Gene Ther       Date:  2017-04-20       Impact factor: 5.250

8.  Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.

Authors:  Johannes Kuehle; Soeren Turan; Tobias Cantz; Dirk Hoffmann; Julia D Suerth; Tobias Maetzig; Daniela Zychlinski; Christoph Klein; Doris Steinemann; Christopher Baum; Juergen Bode; Axel Schambach
Journal:  Mol Ther       Date:  2014-01-17       Impact factor: 11.454

9.  Lentiviral Vectors with Cellular Promoters Correct Anemia and Lethal Bone Marrow Failure in a Mouse Model for Diamond-Blackfan Anemia.

Authors:  Shubhranshu Debnath; Pekka Jaako; Kavitha Siva; Michael Rothe; Jun Chen; Maria Dahl; H Bobby Gaspar; Johan Flygare; Axel Schambach; Stefan Karlsson
Journal:  Mol Ther       Date:  2017-04-20       Impact factor: 11.454

10.  Toward stable gene expression in CHO cells.

Authors:  Esther Y C Koh; Jessna H M Yeo; Steven C L Ho; Yuansheng Yang
Journal:  Bioengineered       Date:  2014 Sep-Oct       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.